Format

Send to

Choose Destination
Diabetes Technol Ther. 2014 Jul;16(7):428-34. doi: 10.1089/dia.2013.0377. Epub 2014 Feb 26.

The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.

Author information

1
1 Department of Information Engineering, University of Padova , Padova, Italy .

Abstract

BACKGROUND:

In 2008, the Food and Drug Administration (FDA) accepted our type 1 diabetes mellitus (T1DM) simulator (S2008), equipped with 100 in silico adults, 100 adolescents, and 100 children, as a substitute for preclinical trials for certain insulin treatments, including closed-loop algorithms. Hypoglycemia was well described in the simulator, but recent closed-loop trials showed a much larger frequency of hypoglycemia events in patients compared with the in silico ones. In order to better describe the distribution of glucose concentration observed in clinical trials, the simulator has recently been updated, and modifications have been accepted by the FDA (S2013). The aim of this study is to assess the validity of the S2013 simulator against clinical data and compare its performance with that of the S2008.

SUBJECTS AND METHODS:

The database consists of 24 T1DM subjects who received dinner (70.7±3.3 g of carbohydrate) and breakfast (52.9±0.1 g of carbohydrate) in two occasions (open- and closed-loop), for a total of 96 postmeal glucose profiles. Measured plasma glucose profiles were compared with those simulated in 100 in silico adults, and the continuous glucose error grid analysis (CG-EGA) was used to assess the validity of the simulated traces. Moreover, the most common outcome metrics have been compared.

RESULTS:

The frequency of hypoglycemia episodes predicted by the S2013 well reproduces that observed during clinical trials as proven by the CG-EGA. In addition, the outcome metrics provided by the S2013 are similar to those observed in clinical trials in a set of T1DM subjects.

CONCLUSIONS:

We demonstrated that the virtual subjects of the S2013 are representative of the T1DM population observed in a clinical trial. We conclude that the S2013 is a valid tool usable to test the robustness of closed-loop control algorithms for artificial pancreas.

PMID:
24571584
PMCID:
PMC4074748
DOI:
10.1089/dia.2013.0377
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center